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The possibility of direct inactivation of C3 by granular enzymes from polymor-
phonuclear leukocytes (PMNLs) in pleural empyema was examined. As a group, pleural
empyema from 10 patients with purulent effusions and a positive bacteriologic culture
cleaved significantly more 125I-labeled C3 bound to Sepharose (18.4070 ± 7.3070) than
did 19sterile pleural effusions (2.4070 ± 0.9070; P« 0.001)and sonicates from bacterial
strains commonly found in empyema (1.4070 ± 0.2070). Granular enzymesfrom 7 x 106
PMNLs cleaved 78.5070 of 125I-labeled C3 bound to Sepharose. When proteolysis of
125I-labeled C3 after incubation with pleural empyema or PMNL granular enzymeswas
examined with polyacrylamide gel electrophoresis, breakdown products were similar.
Granulocyte elastase-like activity was detected in four samples of pleural empyema.
Granulocyte elastase inhibitors, as well as 10070 human serum, effectively suppressed
cleavage of C3 and elastase-like activity. In pleural empyemas, granular enzymes from
PMNLs, especially elastase, apparently contribute to low complement-mediated op-
sonic activity by direct inactivation of C3.
Pleural empyema is a closed-space infection de-
fined by the simultaneous presence of large
numbers of live microorganisms and polymor-
phonuclear leukocytes (PMNLs). The disease is
further characterized by its chronic evolution and
its poor response to medical and sometimes even
surgical therapy.
Work from our laboratory [1] has shown that
the persistence of live microorganisms despite the
presence of large numbers of PMNLs in pleural
empyemas can be partially explained by a marked
decrease in complement-mediated opsonic activity
in culture-positive pleural effusions. This deficien-
cy in opsonic activity was further shown to be
accompanied by the local generation of increased
amounts of C3d, the inactive breakdown product
of C3.
Serum complement is of major importance in
the humoral immune response to pyogenic infec-
tions, and C3 is currently viewed as the target
molecule of both the classical and the alternative
pathways of complement activation [1-3]. Its ac-
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tivation leads to the production of the biologically
active fragment C3b, and the coating of mi-
croorganisms with C3b promotes their recogni-
tion by PMNLs. Activation proceeds through the
cleavage of native C3 by either the classical (C42)
or the alternative (C3b, Bb) pathway convertase of
C3 or both [2, 3]. Recently it has been shown in
vitro [4-8] that C3, as well as C5, can be split by
complement-unrelated enzymes, such as purified
neutral proteases from PMNLs. These reports
have shown that the purified granular enzymes
elastase, collagenase, and cathepsin G can act on
C3 and C5 by splitting small fragments similar in
size to C3a and C5a from the native molecules.
Because these enzymes, especially elastase, act on
a broad spectrum of substrates [9-12], 1 it is con-
ceivable that they could split C3 extensively and
thus generate inactive breakdown products. Such
a mechanism has already been demonstrated in
vitro [8] and could account for our observations
of low complement-mediated opsonic activity, low
complement levels, and high levels of C3d in em-
pyema [1]. We therefore tried to demonstrate
C3-cleaving activity in pleural empyema using a re-
producible in vitro test with purified, radiolabeled
C3 covalently bound to Sepharose as a substrate.
I W. Schmidt, "Neutrale Proteasen aus menschlichen
Leukozyten: Isolierung, charakterisierung und biologische
Wirkungen," inaugural-dissertation, Fachbereich Chemie der
Philipps-Universitat Marburg/Lahn, Federal Republic of Ger-
many, 1975, p. 66.
500 Suteret al.
Table 1. Characteristics of 10 patients with pleural effusions and positive bacteriologic cultures (empyema) in
group 1.
Sex, age Associated Protein concentration No. of
Patient no. (in years) disease Bacteria cultured (g/Iiter) leukocytes/ j.tl
I M,51 Alcoholism Peptococcus, Eubacterium lentum 8 320,000
2 M,57 Carcinoma of the Bacteroides melaninogenicus, 9 340,000
esophagus Pseudomonas aeruginosa,
Streptococcus faecalis
3 F,66 Inactive pulmonary B. melaninogenicus 36 190,000
tuberculosis
4 M,60 None identified Peptococcus, Peptostreptococcus, 40 336,000
Fusobacterium, B. melaninogenicus
5 M,43 None identified P. aeruginosa, Streptococcus, 28 62,000
Fusobacterium, B. melaninogenicus
6 M,26 Teratoseminoma Klebsiella pneumoniae 46 1,350
7 M,26 None identified Peptococcus, Fusobacterium 40 100,000
8 M,71 None identified Streptococcus pneumoniae 33 34,000
9 M,57 Alcoholism .Peptostreptococcus 29 110,000
10 M,20 Multiple trauma Staphylococcus aureus 30 300,000
Patients and Methods
Patients. Twenty-nine patients hospitalized with
pleural effusions at the University Hospital,
Geneva, Switzerland, were divided into two groups.
Group 1 (empyemas) consisted of 10 patients
with purulent effusions and a positive bacterio-
logic culture. Information about these patients
and the bacteriologic results are presented in table
1. Associated diagnoses included alcoholism, inac-
tive pulmonary tuberculosis, carcinoma of the
esophagus, and multiple trauma. The mean age of
the patients was 50 years (range, 20-71 years).
Their pleural fluid had a mean protein concentra-
tion of 30 ± 4 g/liter and a mean leukocyte count
of 172,000 ± 40,000 cells/f.ll.
Group 2 (culture-negative effusions) consisted
of 19 patients with pleural effusions for whom
bacteriologic cultures were negative. Eight pa-
tients had parapneumonic effusions accompany-
ing acute pneumonia. The diagnosis of pneumonia
was established by clinical findings, appropriate
cultures of sputum and/or blood, and chest roent-
genograms. Six patients had pleural effusions
drained after surgery for multiple trauma, cor-
onary heart disease, mitral valve replacement, or
carcinoma of the lung or the esophagus. Three
other patients had metastatic cancer with pleural
effusions, and two patients had transudates
associated with congestive heart failure. Their
mean age was 54 years (range, 32-91 years). The
mean protein concentration in their pleural effu-
sions was 32 ± 3 g/liter, and the mean leukocyte
count was 2,175 ± 1,030 cells/f.ll. The leukocyte
counts in the two groups were significantly dif-
ferent (P« 0.001).
Collection of pleural fluids. Thirty-nine
samples of pleural fluid were collected from these
29 patients. Each sample was processed within 1
hr of thoracocentesis and was separated into two
specimens: one was immediately mixed with EDTA
(final concentration, 20 mu) and the other was
processed without additive. They were centrifuged
(Heraeus-Christ, Osterode, Federal Republic of
Germany) at 1,000 g for 10 min; the supernatants
were separated from the sediment, frozen im-
mediately, and stored at -70 C until used.
Leukocyte counts and protein concentrations were
determined before centrifugation.
Preparation ofgranular enzymes from PMNLs.
Blood freshly obtained from adult volunteers
was treated with heparin (45 units/ml). PMNLs
were isolated by Ficoll-Hypaque centrifugation
and subsequent dextran sedimentation [13]. In
some preparations Ficoll-Hypaque centrifuga-
tion was omitted because the contaminating lym-
phocytes and monocytes did not modify the enzy-
matic activity measured in our tests. PMNLs were
washed three times with 0.9<IJ0 NaCl, and contam-
inating red blood cells were removed by hypotonic
lysis (addition of 9 ml of ice-cold distilled water
for 30 sec and reconstitution of isotonicity by the
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addition of 3 ml of 0.6 MKCI). The resulting cell
pellet was resuspended in 0.2 M sucrose, and the
cell concentration was adjusted to 108/ml. All
subsequent steps were carried out in the cold (4 C).
The cell suspension was homogenized (Braun,
Melsungen, Federal Republic of Germany) at
1,500 rpm for 5 min, and cellular debris was
removed by centrifugation at 12,500 g for 10 min.
The supernatant was used for the isolation of
granules according to the method of Baggiolini
[14]. The supernatant was centrifuged at 12,500 g
for 20 min in an ultracentrifuge (model L5-65;
Beckman Instruments, Palo Alto, Calif.), and the
resulting pellet was extracted with 0.2 M acetate,
pH 4.4, at 4 C for 2 hr with gentle stirring. The
precipitated proteins were removed by ultracentri-
fugation at 100,000 g for 30 min. The supernatant
(volume, 5 ml) containing the granular enzymes
was stored at - 70 C in small aliquots and
neutralized to pH 7.0 with NaOH before use. The
enzymatic activity of different batches extracted
from 450 ml of blood varied over a twofold range.
Purification of human C3 and preparation of
125I-labeled C3 bound to Sepharose. C3 from
human plasma was purified to homogeneity using
the method of Tack and Prahl [15]. It was labeled
with 125 1 (Radiochemical Centre, Amersham,
England) by the chloramine-T method [16]. About
1.5 x 107 cpm were incorporated into 10 fJ.g of
purified C3. Labeled C3 was coupled to cyanogen
bromide-activated Sepharose 4B (Pharmacia Fine
Chemicals, Uppsala, Sweden).
Assessment of C3-cleaving activity. 125 1_
labeled C3 bound to Sepharose was washed with
Dulbecco's phosphate-buffered saline, pH 7.3,
without Ca" or Mg" to remove unbound radioac-
tivity. Samples of 1251-labeled C3 bound to
Sepharose corresponding to 1.5 x 106 cpm, deter-
mined by counting in a gamma counter (Beck-
man), were incubated at 37 C with EDT A-mixed
supernatants of pleural effusions, with granular
enzymes, or with bacterial sonicates and their
culture supernatants. Aliquots were drawn at
timed intervals over 9 hr, and 1251-labeled C3
cleaved from Sepharose was separated from un-
cleaved material by centrifugation at 8,000 g for
10 min. Cleavage of C3 was expressed as percent-
age of cpm in the supernatant divided by the cpm
of the total sample.
Measurement of elastase-like activity. Elas-
tase-like activity was tested with the artificial
substrate succinyl-Ala-Ala-Pro-7-amino-4-methyl-
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coumarin (TGP 928), a gift from M. Baggiolini,
Wander Research Institute, Bern, Switzerland.
Granulocyte elastase selectively cleaves the 7-
aminoA-methyl-coumarin part of the molecule,
which has an extinction coefficient of 12,200 at
360 nm. Because the specificity of this substrate
has been tested with purified enzymes and is not
demonstrable in our biologic system, the term
"elastase-like" was chosen to describe its activity.
Various samples of pleural fluid, granular en-
zymes, or bacterial sonicates were mixed with
TGP 928 (final concentration, 10-3 M) in 0.5 M
phosphate buffer, pH 7.5, and the change in OD
at 360 nm in a spectrophotometer (Beckman) was
observed over a 4-min period. Over this interval,
the enzymatic reaction was linear for all samples
tested. Enzymatic activity was expressed as the in-
crease in OD over 4 min.
Demonstration of proteolysis by culture-
positive pleural effusions of 125l-labeled C3 by
polyacrylamide gel electrophoresis. 1251-labeled
C3 was combined with either the EDT A-mixed
supernatant of a culture-positive effusion from
patient no. 2 or a batch of granular enzymes. A
control aliquot without additive was always as-
sayed simultaneously. After incubation at 37 C for
6 hr, samples withdrawn at timed intervals were
suspended in sodium dodecyl sulfate sample buf-
fer (10,10 2-mercaptoethanol, 20,10 sodium dodecyl
sulfate, 80 mM Tris-HCl [pH 6.8], 100,10 glycerol,
and 0.050,10 bromphenol blue) and heated at 100 C
for 3 min. They were electrophoresed on discon-
tinuous slab gels, with 50,10 (wt/vol) acrylamide in
the stacking gel and 12.50,10 (wt/vol) acrylamide in
the resolving gel [17]. Labeled proteins were
revealed by autoradiography (Xiomat'" S film;
Kodak S.A., Lausanne, Switzerland), with ex-
posure at - 70 C for two days. Molecular weights
were determined by comparison with marker pro-
teins from Sendai virus and vesicular stomatitis
virus [18, 19] labeled with [35S]methionine.
Inhibition experiments. The effects of three
inhibitors of serine proteases were tested on
C3-cleaving activity and elastase-like activity of
culture-positive pleural effusions and granular en-
zyme preparations. Phenyl methyl sulfonylfluo-
ride- was purchased from Sigma Chemical Co.,
St. Louis, Mo. A peptide carbazate inhibitor [20]
was provided by Merck Sharp and Dohme Re-
search Laboratories, Rahway, N.J., and N-ace-
2 See footnote I.
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tyl-(Alakchloromethylketone [21] was a gift from
J. Powers, Georgia Institute of Technology,
Atlanta.
In some experiments, 10070 human serum mixed
with 20 mu EDTA was used as an inhibitor; in
others, samples of pleural fluids or granular en-
zymes were inactivated by heating at 80 C for 10
min.
Preparation of bacterial sonicates and culture
supernatants. Clinical isolates of Streptococcus
pneumoniae, Streptococcus faecalis, group A
(3-hemolytic Streptococcus, Pseudomonas aerug-
inosa, Klebsiella pneumoniae, and Bacteroides
fragilis were obtained by overnight culture in the
appropriate medium. An average of 5 x 109
microorganisms was sedimented by centrifugation
at 3,300 g for 15 min, washed three times in
Dulbecco's phosphate-buffered saline, and resus-
pended in 5 ml of Dulbecco's phosphate-buffered
saline without Ca" or Mg". The bacteria were
lysed by sonication (Sonifer"; Branson, Danbury,
Conn.) on crushed ice for 3 min (intensity, 50 W).
Residual intact bacteria and membranes were
sedimented by centrifugation at 3,300 g for 15
min, and the supernatant was stored at - 20 C un-
til used (always within three days of preparation).
There was a decrease in cfu of >95% in all lysed
bacterial preparations tested, assessed by serial
dilution and plating of the preparations before
and after sonication. The culture supernatant (5
ml), which was obtained after the first sedimenta-
tion of the bacteria, was studied at the same con-
centration as the sonicate.
Complement studies. Complement studies
were all carried out on EDTA-mixed fluids. C3
and (3-1 H levels were measured by single radial
immunodiffusion using monospecific antibodies
to these proteins [22]. The results were expressed
as a percentage of the levels in a pool of normal
human plasma. C3d levels were quantitated in a
two-step procedure [23]. In the first step, native
C3 and the high-molecular-weight fragments C3b
and C3c were precipitated with polyethylenegly-
col. Then the C3d level was measured in the poly-
ethyleneglycol supernatant by single radial im-
munodiffusion with antiserum to C3d. The results
were expressed as a percentage of levels in an
inulin-activated serum. The value for normal
pooled human serum was 9.9%.
Statistics. Results were expressed as means
± SEM. C3-cleaving activity in culture-positive and
culture-negative effusions was compared using the
Suteret al.
rank-sum test. Student's t-test was used to com-
pare levels of complement components, protein
concentrations, and leukocyte counts in infected
and sterile pleural effusions.
Results
C3-cleaving activity. C3-cleaving activity was
evaluated by incubating the EDTA-mixed super-
natants of effusions from patients in group 1 and
group 2 with 125 I-labeled C3 bound to Sepharose
(figure 1). The amount of C3 cleaved by culture-
positive effusions increased with time, reaching a
level of 18.4% ± 7.3% (range, 0.9%-67.2%),
whereas culture-negative -effusions cleaved only
2.4% ± 0.9% of the labeled, bound C3 (range,
1.1%-3.4%) after incubation for 9 hr (P «
0.001). 1251-labeled C3 bound to Sepharose was in-
cubated alone with each experiment as a control;
30
Incubation at 37 C (minutes)
Figure 1. Percentage cleavage of WI-labeled C3
bound to Sepharose by effusions from 10 patients with
positive bacterial cultures (0) and 19 patients with nega-
tive bacterial cultures (.). Labeled, bound C3 (1.5 x
106 cpm) in 1.2 ml of Dulbecco's phosphate-buffered sa-
line, pH 7.3, without Ca'" and Mg" was incubated at 37
C with 0.3 ml of EDT A-mixed supernatant of pleural ef-
fusions, and timed sampling of 0.2-ml aliquots was per-
formed over 9 hr. The data are mean ± SEM cpm in the
supernatant/cpm in the total sample x 100. At 540 min,
the difference in cleavage was statistically significant (P
« 0.001).
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Table 2. Cleavage of 1'51-labeled C3 bound to Sepha-
rose by sonicates of clinical bacterial isolates.
Microorganism
Klebsiella pneumoniae
Streptococcus faecalis
Streptococcus pneumoniae
Group A f3-hemolytic Streptococcus
Pseudomonas aeruginosa
Staphylococcus aureus
Bacteroides fragilis
Mean ± SEM
Percentage cleavage
1.3
2.3
l.l
1.0
1.3
1.3
1.3
1.4 ± 0.2
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Figure 2. Percentage cleavage of I "J-labeled C3
bound to Sepharose by (top) a culture-positive pleural
effusion from patient no. 2 and (bottom) a preparation
(batch I) of granular enzymes from normal human poly-
morphonuclear leukocytes. Labeled, bound C3 (1.5 x
106 cpm) in 1.2 ml of Dulbecco's phosphate-buffered sa-
line, pH 7.3, without CaH and MgH was incubated at
various temperatures with 0.3 ml of either EDTA-mixed
supernatant of empyema or granular enzyme prepara-
tion without EDTA, and timed sampling of 0.2-ml ali-
quots was performed over 9 hr. The data for empyema
tested at 37 C are mean ± SEM cpm in the super-
natant/cpm in the total sample x lOO for triplicate
determinations.
buffer of pH 8.2 than of pH 6. These findings
agree with those of Schmidt," who defined an op-
timal pH of 8 for granulocyte elastase when tested
against a protein substrate.
The proteolytic nature of C3 cleavage by
culture-positive effusions and preparations of
PMNL granular enzymes was studied (figure 3).
1251-labeled C3 bound to Sepharose was mixed
with a culture-positive effusion and a granular en-
zyme preparation and incubated for 6 hr. Samples
were tested by polyacrylamide gel electrophoresis
at timed intervals for proteolytic breakdown, and
the a-chain and (3-chain of C3 [8] were located in
reference to the marker proteins. 125I-labeled C3
bound to Sepharose was also incubated alone as a
control. In the mixtures of 125I-labeled C3 bound
NOTE. Bacterial sonicates (300 iii) corresponding to 1-2 x
10' lysed organisms were incubated for 24 hr with "'I-labeled
C3 bound to Sepharose (1.5 x 106 cpm) in 1.2 ml of Dulbec-
co's phosphate-buffered saline, pH 7.3, without Ca " and
Mg". Data are percentage of cpm in the supernatant/cpm
added to the suspension for triplicate determinations.
spontaneous breakdown or release of iodine was
only 0.3070 ± 0.2070 over a 9-hr period. Thus,
significant cleavage of bound C3 was observed in
the culture-positive group as compared with the
culture-negative group. In further experiments,
granular enzymes from PMNLs were incubated
with 1251-labeled C3 bound to Sepharose;
cleavage of bound C3 occurred with similar
kinetics to the reaction with effusions. After in-
cubation for 9 hr, the granular enzyme prepara-
tion from 7 x 106 PMNLs (batch 3) cleaved
78.5070 of 125I-labeled C3 bound to Sepharose.
Cleavage was 34070 at 90 min, 54070 at 180 min, and
70070 at 360 min (data not shown).
In contrast to the C3-cleaving activity of
culture-positive effusions and the granular enzyme
preparation, none of seven bacterial sonicates
cleaved bound C3 significantly more than did cul-
ture-negative (control) effusions (table 2). Even
after incubation for 24 hr, only 1.4070 ± 0.2070
(range, 1.0070-2.3070) of the I 25I-labeled C3 bound
to Sepharose was cleaved. No significant C3-
cleaving activity was observed with the culture su-
pernatants except for that of P. aeruginosa, which
cleaved 15070 of the labeled, bound C3.
Enzymatic nature of C3-cleaving activity. To
explore more precisely the mechanism responsible
for C3 cleavage in empyemas, the cleavage of
125I-labeled C3 bound to Sepharose by culture-
positive effusions and PMNL granular enzymes
(batch 1) was assessed in parallel at various
temperatures and at different pH values of the
reaction buffer. C3-cleaving activity was optimal
at 37 C, compared with 20 C, 10 C, and 4 C (figure
2). C3-cleaving activity was greater at 37 C in a
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Figure 3. Autoradiogram after poly-
acrylamide gel electrophoresis of
(lanes 1-4) 20 fll of a granular enzyme
preparation (batch I) from normal
human polymorphonuclear leuko-
cytes and (lanes 5-8) 20 /AI of pleural
empyema from a patient with posi-
tive bacterial cultures mixed with
]lSI-labeled C3 bound to Sepharose.
Labeled, bound C3 was electro-
phoresed alone (lanes 9 and 10) as a
control, and Sendai virus (lane II)
and vesicular stomatitis virus (lane
12) were used to determine molecular
masses. The a-chain and the (3-chain
of C3 appear at 110 and 74 x 103
daltons, respectively. The estimated
molecular masses of the breakdown
products of C3 are 32,25,23, and 18
x 103 daltons.
to Sepharose with a granular enzyme preparation
and with a culture-positive effusion, the amount
of a-chain decreased gradually as a function of
length of incubation, while, simultaneously,
breakdown products with smaller molecular
masses appeared: 32,25, and 18x 103 daltons with
the empyema and 32, 23, and 18 x 103 daltons
with the granular enzymes. After incubation for 6
hr, the amount of {3-chain also slightly decreased.
In contrast, none of these small breakdown prod-
ucts appeared in the control incubation. Thus,
both the EDTA-mixed supernatant of the culture-
positive effusion and the granular enzyme
preparation have proteolytic activity on C3, par-
ticularly on its a-chain.
To explore the nature of the C3-cleaving activity
in empyema, we used human serum mixed with
EDTA (final concentration, 20 msr) as a source of
aI-antitrypsin and az-macroglobulin, the two
natural inhibitors of PMNL granular enzymes in
serum [24]. EDTA-mixed 100/0 human serum was
added to pleural effusions from patients no. 1 and
no. 2 (with the highest C3-cleaving activity) in
group 1 and to granular enzyme preparations, and
the specimens were preincubated at room
temperature (about 20 C) for 10 min. When they
were tested after incubation for 6 hr at 37 C,
C3-cleaving activity was almost totally inhibited
(table 3).
Elastase-like activity. Because the preceding
results suggested that granulocyte elastase was a
candidate for the neutral proteases responsible for
breakdown of C3 [4, 5, 8], we tried to compare the
C3-cleaving activity in empyema with that in a
granular enzyme preparation using an elastase-
specific substrate (TGP 928) and three inhibitors
known to inhibit specifically serine proteases such
as granulocyte elastase [20, 21].4 Elastase-like ac-
tivity, as measured with the substrate TGP 928,
could be detected in the granular enzyme prepara-
tions and all of the CUlture-positive effusions that
cleaved >18% of the lz5I-labeled C3 bound to
Sepharose in our test. There was a linear correla-
tion between the amount of C3-cleaving activity
and the amount of elastase-like activity in the four
samples of empyema that gave positive results
with the assay for elastase-like activity and the two
preparations of granular enzymes used (figure 4).
No elastase-like activity was detected in the
bacterial sonicates or in the culture supernatants.
Inhibition experiments. Phenyl methyl sul-
fonylfluoride (2 mu), a peptide carbazate in-
See footnote 1.
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hibitor (2.5 rna), and N-acetyl-(Alakchloro-
methylketone (2.5 rna) were analyzed for their
ability to inhibit the C3-cleaving activity and
elastase-like activity of two culture-positive effu-
sions and a granular enzyme preparation (table 3).
The degree of inhibition ranged from 610,10 to
1000,10. The peptide carbazate inhibitor and the
chloromethylketone were more potent inhibitors
of elastase-like activity than of C3-cleaving activi-
ty for both the granular enzyme preparation and
the culture-positive effusions.
Concentrations of C3, C3d, and ~-lH in pleural
fluids. Pleural effusions from patients in group
1 had a level of C3 of 450,10 ± 90,10, of C3d of 800,10
± 120,10, and of ~-IH of 970,10 ± 290,10. Ineffusions
of the control patients (group 2), the level of C3
was 340,10 ± 60,10, of C3d was 250,10 ± 60,10, and of
~-IH was 780,10 ± 130,10. Between the two patient
groups the levels of C3 and ~-1H were not signifi-
cantly different, whereas levels of C3d were signif-
icantly higher in the culture-positive group than in
the culture-negative group (P < 0.02).
Discussion
The most significant finding of the present study is
the demonstration of an enzymatic activity that
cleaved C3 in pleural effusions from patients with
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empyema, whereas culture-negative effusions of
various etiologies were devoid of such activity.
The breakdown of C3 through activation of the
classical and/or the alternative pathways of com-
plement as a trivial explanation of our findings
was eliminated because the experiments were per-
formed in the absence of divalent cations. The
enzymatic nature of the C3-cleaving activity was
substantiated by its temperature-dependence, its
destruction by heat, and its inhibition by the addi-
tion of EDTA-mixed 100,10 normal human serum
as a source of the natural inhibitors a I-antitrypsin
and az-macroglobulin [24].
We have tried to assign the origin of this en-
zymatic activity either to bacteria or to PMNLs
by, respectively, studying bacterial sonicates from
a variety of strains which are classically isolated as
the causative agents of empyema and a granular
enzyme preparation of human PMNLs. None of
the bacterial sonicates cleaved C3 significantly,
whereas activities of the granular enzyme prepara-
tions and culture-positive effusions were similar:
the time curves and the optimal pH for cleavage
with the same amount of substrate were essentially
the same. It is conceivable that a proteolytic en-
zyme of bacterial origin contributed to C3 cleav-
age in the effusions of patients no. 2 and no. 5,
from whom P. aeruginosa was isolated. This
Table 3. Characterization of C3-cleaving activity in pleural empyema and preparations of granular enzymes from
normal human polymorphonuclear leukocytes.
------------
Inhibition (070) of
----_._---_. ---_._--- --~_.~
Cf-cleaving activity Elastase-like activity
-----_.
Empyema Empyema Granular Empyema Empyema Granular
Inhibitor no. \ no. 2 enzymes no. 1 no. 2 enzymes
_._---_.-
Human serum (10070) + EDTA
(20 msr) 97 98 98 \00 \00 90
Phenyl methyl sulfonyl fluoride
(2 rna) 77 96 99 80 100 80
Peptide carbazate inhibitor
(2.5 rna) 80 69 64 90 97 94
Chloromethylketone (2.5 mu) 66 62 61 70 69 90
NOTE. C3-cleaving activity and its inhibition were quantitated by incubation of 40/-11 of granular enzyme preparation or pleural
effusion (from patient no. 1 or no. 2) in 200 /-II of Dulbecco's phosphate-buffered saline (pH 7.3) without Ca" or Mg" containing
200,000 cpm of '''I-labeled C3 bound to Sepharose for 6 hr with and without inhibitor. The empyema specimens and granular en-
zymes were preincubated with the inhibitor for 10 min at room temperature (about 20 C) and then incubated at 37 C except for
chloromethylketone and peptide carbazate inhibitor (Merck Sharp and Dohme Research Laboratories, Rahway, N.J.), which were
tested at room temperature. Elastase-like activity was tested at room temperature in l-rnl samples of 0.5 M phosphate buffer (pH
7.5) containing 100 /-II of empyema or granular enzymes. The substrate succinyl-Ala-Ala-Pro-7-amino-methyl-coumarin (TGP 928)
was added (final concentration, 10-3 M), and each sample was tested with or without inhibitor. The samples were preincubated with
the inhibitor as described above. Inhibition is expressed as 100 - (jactivity of sample with inhibitor/activity of sample without in-
hibitor] x 1(0).
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tic activity of other granular enzymes such as
cathepsin G.
The results of our experiments therefore suggest
that elastase is one of the proteases involved in the
cleavage of C3. Indeed, elastase and collagenase
are present in large amounts in granulocytes,
representing ""5% of the dry weight of the cell
[26], in comparison to cathepsin G, which is pres-
ent in much smaller quantities. Elastase and
cathepsin G are located in the primary granules
and collagenase in the secondary granules of
granulocytes [27]. Upon phagocytosis, these
granules, in addition to fusing intracellularly with
the phagosome, may be released into the sur-
rounding medium [26, 28]. Thus, it is conceivable
that these enzymes may be detected extracellularly
in a purulent infection with high bacterial concen-
trations, such as empyema. Three neutral pro-
teases from PMNLs have been shown to cleave C3
in vitro [4, 5, 8]: elastase, collagenase, and cathep-
sin G. Collagenase is calcium-dependent and in-
hibited by EDTA [26]; it cannot be involved in the
C3-cleaving activity of our culture-positive pleural
effusions because all experiments were carried out
in the absence of Ca". Cathepsin G may be partly
responsible for the C3-cleaving activity observed
in our tests, despite the fact that this enzyme has
only minimal activity on the elastase-specific
substrate used in our experiments. Another en-
zyme, present in the cytosol of PMNLs, is the
plasminogen activator described by Granelli-
Piperno et al. [29]; the activity of this enzyme can
only be detected if cell lysates are prepared in the
presence of elastase inhibitors, presumably be-
cause it is otherwise exposed to proteolytic
degradation by elastase. Because we detected
elastase-like activity in several culture-positive ef-
fusions, the plasminogen activator was probably
destroyed.
The pattern of proteolysis of C3 could be fur-
ther established by polyacrylamide gel electro-
phoresis for both a culture-positive effusion and
granular enzymes (figure 3). The pattern of the
breakdown products obtained in our experiments
indicates that the cleavage of the molecule C3 pro-
ceeds beyond cleavage in C3a and C3b, both frag-
ments with biologic activity. The fragments ob-
served in our experiments had molecular masses of
32, 25, 23, and 18 x 103 daltons. The presence of
these small fragments and the simultaneous disap-
pearance of the a-chain indicate that, at the end of
the incubation period of 6 hr, no C3b was present
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microorganism is known to secrete a proteolytic
enzyme that cleaves C3 and other complement
components [25]. However, patient no. 2 had a
very high C3-cleaving activity (67070), whereas the
amount of enzyme secreted under optimal condi-
tions by 1-2 x 108 P. aeruginosa cleaved only
15% of the labeled, bound C3. In addition, the ef-
fusion from patient no. 2 had the highest elastase-
like activity observed, whereas the culture super-
natant of P. aeruginosa had no detectable activity
on this substrate. The effusion from patient no. 5
had no elastase-like activity and a C3-cleaving ac-
tivity of 5.8%. An elastase-like activity could be
demonstrated by means of an elastase-specific,
synthetic substrate in some of the most "active"
culture-positive effusions, and a correlation of
C3-cleaving and elastase-like activity was observed
in these cases. Both C3-cleaving and elastase-like
activities were inhibited by EDTA-mixed 10%
normal human serum and by three serine protease
inhibitors. The peptide carbazate inhibitor and the
chloromethylketone are considered to be specific
inhibitors of granulocyte elastase [20, 21]. In both
systems tested - that is, granular enzymes and
culture-positive effusions - these two compounds
were more potent inhibitors of elastase-like activi-
ty than of the C3-cleaving activity. There are two
possible explanations for these findings. First,
both inhibitors may be more efficient inhibitors of
the esterolytic activity (TGP 928 is an ester sub-
strate) than of the proteolytic activity (with C3 as
substrate) of the enzyme(s). Alternatively, the resi-
dual C3-cleaving activity may reflect the proteoly-
Lgranular Jenzymes
Figure 4. Linear correlation between C3-cleaving ac-
tivity(Zl)and elastase-like activity (D) in twobatchesof
granular enzymes from normal human polymor-
phonuclear leukocytes and four samples of pleural em-
pyema from patients with positive bacterial cultures
withelastase-like activity. C3-cleaving activity isgiven as
percentage cleavage of 125I-labeled C3 bound to
Sepharose after incubation for 9 hr at 37 C, and
elastase-like activity is given as change in OD at 360nm
overa 4-minperiod with the substratesuccinyl-Ala-Ala-
Pro-7-amino-4-methyl-coumarin (TOP 928).
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(this fragment has a molecular mass estimated at
180 x 103 daltons) [3].
That high levels of C3d in culture-positive effu-
sions were found in two other studies of empyema
[1, 30] further supports the proposal of increased
breakdown of C3 in empyema. Because, accord-
ing to Taylor et al. [8], uncontrolled digestion of
C3 with granulocyte elastase also leads to a frag-
ment similar to C3d, it can be postulated that
these high levels of C3d reflect not only comple-
ment-mediated breakdown of C3 but also the ac-
tion of granulocyte elastase.
No significant difference in the levels of C3 and
~-1H could be found between effusions from pa-
tients in group 1 and group 2. The lack of differ-
ence in C3 levels between the two groups may be
explained by the cross-reaction of breakdown
products of C3 with antibody and thus may not re-
flect biologically active C3. This suggestion is sup-
ported by the finding of Lew et al. [1] that, despite
the presence of high levels of immunoreactive C3,
levels of total hemolytic complement were low in
empyema specimens.
In earlier reports conversion of C3 and C5 by
neutral proteases in vitro has been demonstrated
in conditions where a I-antitrypsin and armacro-
globulin were absent [5-8]. When measured in
serum [4], conversion of C3 and C5 by elastase
and collagenase did not occur until the molar ratio
of the enzyme to the inhibitor was>1. Our dem-
onstration of C3 cleavage in empyema clearly indi-
cates that the inhibitor potential of empyema
samples is too low to inactivate all of the enzyme
present. This explanation is further supported by
the fact that enzymatic activity in empyema fluid
was almost totally abolished when EDT A-mixed
10070 normal human serum was added. What are
the possible mechanisms influencing the inhibitor
concentration in the pleural space? Insufficient in-
flux or synthesis in the infected pleural space may
be one explanation. Another is that bacteria might
be implicated in the reduction of the local inhibi-
tor potential. Indeed, P. aeruginosa and Proteus
mirabilis, both of which are occasionally re-
covered from the pleural space, have been ob-
served to destroy ai-antitrypsin [31, 32]. It may be
that these bacteria, as well as other species of
bacteria, might destroy this inhibitor in empyema
specimens.
The finding of a "permissive" environment for
the activity of neutral proteases from PMNLs in
pleural empyema suggests that a broad spectrum
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of substrates may be considered as potential
targets for these enzymes. Among the important
factors responsible for humoral immunity, IgG
and IgM are known to be cleaved by elastase in
vitro [11, 12]. Also, previous work has shown that
125I-Iabeled IgG was hydrolyzed by empyema
fluids and that levels of IgG and IgM in these
fluids were low [30].
In conclusion, the present study describes the
presence of a C3-cleaving enzymatic activity in
empyema. Our results show that the local inhibi-
tor potential in empyema is too low to inactivate
the C3-cleaving activity. This activity is not identi-
cal with that of complement-derived enzymes, and
its characteristics are very similar to those of
granular enzymes from human granulocytes. From
studies of substrate and inhibitor specificity, we
conclude that granulocyte elastase is one of the
granular enzymes involved in the complement-
independent C3 cleavage. Because complement-
mediated opsonic activity has been shown to be
strikingly reduced in empyema [1] and because the
enzymatic activity described in the present study
promotes a thorough breakdown of C3, an insuf-
ficient quantity of C3b, the biologically active
compound of C3, may be one of the consequences
of this enzymatic activity. Therefore, the coating
of microorganisms with C3b could be deficient. In
turn, this result could impair their recognition by
PMNLs and thus be one of the factors conducive
to the persistence of bacteria in empyema.
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